综述

闽台青草药非物质文化遗产人工智能化传承创新战略构想

展开
  • (厦门大学药学院,福建 厦门 361105)

收稿日期: 2025-10-27

  录用日期: 2026-01-12

  网络出版日期: 2026-04-30

基金资助

福建省科协科技创新智库课题(FJKX-2024XKB001)

Strategic Conception for AI-driven Inheritance and Innovation of Min-Tai Herbal Medicine Intangible Cultural Heritage

Expand
  • (School of Pharmaceutical Sciences, Xiamen University, Xiamen 361105, Fujian China)

Received date: 2025-10-27

  Accepted date: 2026-01-12

  Online published: 2026-04-30

摘要

闽台青草药非物质文化遗产,融合中原中医药理论与闽台地域智慧,在当代面临传承断层、应用萎缩、产业分散与科研不足等多重挑战。本文基于模式创新视角,指出其困境根源在于农耕文明个体化经验与工业文明标准化模式之间的内在冲突。本文提出以人工智能与大数据技术为驱动,通过“信用-信心-信念”三阶段战略路径,构建真实世界数据平台与AI辅助诊疗系统,实现闽台青草药从传统经验到智能个性化服务的转型。本文从文化、科技、临床与产业四方面论证转型价值,为闽台青草药的非遗保护与创新发展提供系统性解决方案,对推动区域中医药现代化、落实“健康中国”与“数字中国”战略具有重要参考意义。

本文引用格式

丘鹰昆 . 闽台青草药非物质文化遗产人工智能化传承创新战略构想[J]. 亚热带植物科学, 2026 , 55(2) : 249 -254 . DOI: 10.3969/j.issn.1009-7791.2026.02.013

Abstract

The intangible cultural heritage of Min-Tai (Fujian and Taiwan) herbal medicine, which integrates traditional Chinese medicine theories with the regional wisdom of Fujian and Taiwan, currently faces multiple challenges such as a gap in inheritance, declining application, low industrial aggregation, and insufficient scientific research. From the perspective of model innovation, this paper points out that the root of these challenges lies in the inherent conflict between the individualized experience of agricultural civilization and the standardized model of industrial civilization. This paper proposes a strategy driven by artificial intelligence and big data technology, following a three-stage path of 'credit-confidence-conviction' to build a real-world data platform and an AI-assisted diagnosis and treatment system. This approach aims to elevate Min-Tai herbal medicine from traditional experience to intelligent, personalized services, achieving a transformation. The paper demonstrates the value of this transformation from cultural, technological, clinical, and industrial perspectives, offering systematic solutions for the preservation and innovative development of this intangible cultural heritage. It also provides significant reference for advancing the modernization of regional traditional Chinese medicine and implementing the 'Healthy China' and 'Digital China' strategies.

参考文献

[1]  李丹婷. 深化闽台中医药融合发展的若干思考[J]. 中医药管理杂志, 2021, 29(13): 243–246.

[2]  许克祥, 黄国辉. 闽台中药产业市场发展困境原因探析[J]. 海峡科学, 2013(5): 43–45.

[3]  国务院. 国务院关于印发中医药发展战略规划纲要(2016 —2030年)的通知[EB/OL]. (2016-02-26)[2025-10-27]. https:// www.gov.cn/zhengce/zhengceku/2016-02/26/content_5046678.htm

[4]  胡慧娟. 闽台吴夲信仰与健康文化传播研究[D]. 漳州: 闽南师范大学硕士学位论文, 2024.

[5]  张元一, 彭榕华. 试论闽台医缘关系[J]. 福建史志, 2025, 245(2): 21–29.

[6]  福建省人民政府办公厅. 福建省“十四五”中医药健康发展规划[Z]. 2022.

[7]  任娟莉, 任杰. 太白草药医学的历史文化价值[J]. 陕西中医, 2013, 34(7): 935–937.

[8]  屠呦呦, 倪慕云, 钟裕容. 中药青蒿化学成分的研究Ⅰ[J]. 药学学报, 1981(5): 366–370.

[9]  新华社. 中共中央 国务院印发《“健康中国2030”规划纲要》[N]. 人民日报, 2016-10-26(1).

[10]  黄璐琦. 将中医药融入创新驱动战略[N]. 中国科学报, 2017-6-28(1).

[11]  Yun D Y, Wu X H, Chen X, Yang Y H, Shang Y J, Liu S P, Gunasekeran D V, Lin D R, Liu L X, Zhao L Q, Chen W B, Chen J J, Jin L, Wu Y X, Hong J M, Hu W L, Lin Z Z, Cheung C Y, Chen X, Xie P C, Liu Z Z, Ding C H, Yu-Wai-Man P, Yu K N, Shu W T, Liu Y Z, Zheng Z B, Zhao G S, Xa Z H, Wong T Y, Lin H T. An artificial intelligence and blockchain technology-based data management framework for multicenter randomized controlled trials [J]. Science Bulletin, 2025, 70(6): 856–860.

文章导航

/

〈 〉